Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (441-450 of 514) with videos related to

Pageof 52
Sort By:
European Urology|September 6, 2018
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic HeterogeneityMarthe Løvf, Sen Zhao, Ulrika Axcrona, et al.
Clinical Colorectal Cancer|November 25, 2020
Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant SettingCamila S Araujo, Camila M Venchiarutti Moniz, Renata C Bonadio, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 30, 2014
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patientsM P Freire, L C Pierrotti, H H C Filho, et al.
Familial Cancer|November 22, 2019
Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome)Vanessa Petry, Renata Colombo Bonadio, Allyne Queiroz Carneiro Cagnacci, et al.
Journal of Gastrointestinal Cancer|September 9, 2017
Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer PatientsGustavo Dos Santos Fernandes, Maria Ignez Braghiroli, Michelle Artioli, et al.
Diseases of the Colon and Rectum|November 14, 2021
Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant ChemoradiotherapyGuilherme Cutait Cotti, Rafael Vaz Pandini, Oddone F M Braghiroli, et al.
The Oncologist|June 9, 2019
Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb TrialRachel P Riechelmann, Luiz S Leite, Giovanni M Bariani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.
Emergency Medicine Journal : EMJ|October 29, 2008
Knowledge of signs, treatment and need for urgent management in patients presenting with an acute ischaemic stroke or transient ischaemic attack: a prospective studyL G Stead, L Vaidyanathan, M F Bellolio, et al.
American Journal of Clinical Oncology|April 25, 2001
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancerN A Janjan, C Crane, B W Feig, et al.
Pageof 52

Showing results (441-450 of 514) with videos related to

Sort By:
Pageof 52
European Urology|September 6, 2018
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic HeterogeneityMarthe Løvf, Sen Zhao, Ulrika Axcrona, et al.
Clinical Colorectal Cancer|November 25, 2020
Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant SettingCamila S Araujo, Camila M Venchiarutti Moniz, Renata C Bonadio, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 30, 2014
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patientsM P Freire, L C Pierrotti, H H C Filho, et al.
Familial Cancer|November 22, 2019
Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome)Vanessa Petry, Renata Colombo Bonadio, Allyne Queiroz Carneiro Cagnacci, et al.
Journal of Gastrointestinal Cancer|September 9, 2017
Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer PatientsGustavo Dos Santos Fernandes, Maria Ignez Braghiroli, Michelle Artioli, et al.
Diseases of the Colon and Rectum|November 14, 2021
Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant ChemoradiotherapyGuilherme Cutait Cotti, Rafael Vaz Pandini, Oddone F M Braghiroli, et al.
The Oncologist|June 9, 2019
Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb TrialRachel P Riechelmann, Luiz S Leite, Giovanni M Bariani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.
Emergency Medicine Journal : EMJ|October 29, 2008
Knowledge of signs, treatment and need for urgent management in patients presenting with an acute ischaemic stroke or transient ischaemic attack: a prospective studyL G Stead, L Vaidyanathan, M F Bellolio, et al.
American Journal of Clinical Oncology|April 25, 2001
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancerN A Janjan, C Crane, B W Feig, et al.
Pageof 52